[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Browse HCST

Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Membrane Single-pass type I membrane protein
Domain PF07213 DAP10 membrane protein
Function

Transmembrane adapter protein which associates with KLRK1 to form an activation receptor KLRK1-HCST in lymphoid and myeloid cells; this receptor plays a major role in triggering cytotoxicity against target cells expressing cell surface ligands such as MHC class I chain-related MICA and MICB, and UL16-binding proteins (ULBPs); these ligands are up-regulated by stress conditions and pathological state such as viral infection and tumor transformation. Functions as docking site for PI3-kinase PIK3R1 and GRB2. Interaction of ULBPs with KLRK1-HCST triggers calcium mobilization and activation of the PIK3R1, MAP2K/ERK, and JAK2/STAT5 signaling pathways. Both PIK3R1 and GRB2 are required for full KLRK1-HCST-mediated activation and ultimate killing of target cells. In NK cells, KLRK1-HCST signaling directly induces cytotoxicity and enhances cytokine production initiated via DAP12/TYROBP-associated receptors. In T-cells, it provides primarily costimulation for TCR-induced signals. KLRK1-HCST receptor plays a role in immune surveillance against tumors and is required for cytolysis of tumors cells; indeed, melanoma cells that do not express KLRK1 ligands escape from immune surveillance mediated by NK cells.

> Gene Ontology
 
Biological Process GO:0014065 phosphatidylinositol 3-kinase signaling
GO:0014066 regulation of phosphatidylinositol 3-kinase signaling
GO:0014068 positive regulation of phosphatidylinositol 3-kinase signaling
GO:0048015 phosphatidylinositol-mediated signaling
GO:0048017 inositol lipid-mediated signaling
Molecular Function GO:0043548 phosphatidylinositol 3-kinase binding
Cellular Component -
> KEGG and Reactome Pathway
 
KEGG hsa04650 Natural killer cell mediated cytotoxicity
Reactome R-HSA-1280218: Adaptive Immune System
R-HSA-168256: Immune System
R-HSA-198933: Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between HCST and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 
  Literatures describing the relation between HCST and anti-tumor immunity in human cancer.
PMID Cancer type Relation to immunity Evidence sentences
17785813MelanomaInhibit immunity (NK cell function)Mice lacking DAP10 (DAP10KO), showed enhanced immunity against melanoma malignancies due to hyperactive functioning of NK1.1+CD3+ NKT cells. DAP10 deficiency resulted in substantially increased NKT cell functions, including cytokine production and cytotoxicity, leading to efficient killing of melanoma tumors. Moreover, the antitumor phenotype of DAP10KO mice correlated with impaired activation status of CD4+CD25+ T regulatory cells (Tregs).
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of HCST in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of HCST in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.5770.242
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.5610.83
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.5860.757
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.4430.582
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.1750.883
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.8010.621
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.0920.852
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15110.3970.683
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 1112-0.3330.771
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 480.9430.644
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 280.0680.983
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.1530.428
> Mutation difference between responders and non-responders
 

There is no record.

Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of HCST. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of HCST. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by HCST.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of HCST. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of HCST expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between HCST and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolHCST
Namehematopoietic cell signal transducer
Aliases DAP10; DKFZP586C1522; KAP10; DNAX-activation protein 10; kinase assoc pro of ~10kDa; PIK3AP; phosphoinositid ......
Chromosomal Location19q13.1
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting HCST collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.